Atherosclerosis
Volume 213, Issue 1 , Pages 67-76, November 2010

Bone marrow mononuclear cells reduce myocardial reperfusion injury by activating the PI3K/Akt survival pathway

  • Matthew J. Lovell

      Affiliations

    • Centre for Clinical Pharmacology, Cardiovascular Biomedical Research Unit, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • These authors have contributed equally and are joint first authors of this article.
    • ,
  • Mohammed Yasin

      Affiliations

    • Centre for Translational Medicine & Therapeutics, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • These authors have contributed equally and are joint first authors of this article.
    • ,
  • Kate L. Lee

      Affiliations

    • Centre for Clinical Pharmacology, Cardiovascular Biomedical Research Unit, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • ,
  • King Kenneth Cheung

      Affiliations

    • Centre for Advanced Biomedical Imaging, Department of Medicine and Institute of Child Health, University College London, London WC1E 6DD, UK
    • Department of Medical Physics and Bioengineering, University College London, London WC1E 6DD, UK
    • ,
  • Yasunori Shintani

      Affiliations

    • Centre for Translational Medicine & Therapeutics, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • ,
  • Massimo Collino

      Affiliations

    • Centre for Translational Medicine & Therapeutics, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • ,
  • Ahila Sivarajah

      Affiliations

    • Centre for Translational Medicine & Therapeutics, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • ,
  • Kit-yi Leung

      Affiliations

    • Centre for Clinical Pharmacology, Cardiovascular Biomedical Research Unit, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • ,
  • Kunihiko Takahashi

      Affiliations

    • Centre for Translational Medicine & Therapeutics, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • ,
  • Amar Kapoor

      Affiliations

    • Centre for Translational Medicine & Therapeutics, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • ,
  • Mohammed M. Yaqoob

      Affiliations

    • Centre for Translational Medicine & Therapeutics, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • ,
  • Ken Suzuki

      Affiliations

    • Centre for Translational Medicine & Therapeutics, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • ,
  • Mark F. Lythgoe

      Affiliations

    • Centre for Advanced Biomedical Imaging, Department of Medicine and Institute of Child Health, University College London, London WC1E 6DD, UK
    • ,
  • John Martin

      Affiliations

    • British Heart Foundation Laboratories, Department of Medicine, University College London, London WC1E 6JJ, UK
    • ,
  • Patricia B. Munroe

      Affiliations

    • Centre for Clinical Pharmacology, Cardiovascular Biomedical Research Unit, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • ,
  • Chris Thiemermann

      Affiliations

    • Centre for Translational Medicine & Therapeutics, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • These authors have contributed equally and are joint last authors of this article.
    • ,
  • Anthony Mathur

      Affiliations

    • Centre for Clinical Pharmacology, Cardiovascular Biomedical Research Unit, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK
    • These authors have contributed equally and are joint last authors of this article.
    • Corresponding Author InformationCorresponding author. Tel.: +44 208 983 2216; fax: +44 208 983 2381.

Received 13 January 2010; received in revised form 22 July 2010; accepted 23 July 2010. published online 01 September 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0021-9150(10)00590-3

doi:10.1016/j.atherosclerosis.2010.07.045

Atherosclerosis
Volume 213, Issue 1 , Pages 67-76, November 2010

Article Tools

* Image Usage & Resolution